genotypic profile
Showing 1 - 25 of 9,375
Phenotypic and Genotypic Variations of Enterococcus Spp
Not yet recruiting
- Isolation of Enterococci From Samples
- +5 more
- Culture
- +7 more
- (no location specified)
Mar 1, 2023
HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)
Active, not recruiting
- HIV-1-infection
- Clinical management informed by HIV-1 genotypic resistance testing
-
Seboche, Butha-Buthe, Lesotho
- +9 more
Dec 4, 2022
Molecular and Genomic Profiling of Head and Neck Tumors
Recruiting
- Head and Neck Neoplasms
-
Bronx, New YorkStelby Augustine
Feb 17, 2022
Evaluate Doravirine Based-regimens in HIV Infected Aged
Recruiting
- HIV
-
Rome, Italy/RM, ItalyDepartment of Public Health and Infectious Diseases
Jan 11, 2022
Exostoses, Multiple Hereditary Trial in Bologna (blood and buccal swab genetic test, PUL, Range of motion)
Completed
- Exostoses, Multiple Hereditary
- blood and buccal swab genetic test
- +2 more
-
Bologna, ItalyManila Boarini
Jun 21, 2023
Non-cancerous Chronic Pain Trial in Nîmes (Pharmacogenetic analysis allowing personalized opioid prescription, Standard opioid
Not yet recruiting
- Non-cancerous Chronic Pain
- Pharmacogenetic analysis allowing personalized opioid prescription
- Standard opioid prescription
-
Nîmes, FranceCHU Nimes
Jan 24, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Multiple Myeloma Trial (Bone marrow sampling)
Not yet recruiting
- Multiple Myeloma
- Bone marrow sampling
- (no location specified)
Jul 11, 2023
Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))
Recruiting
- Hepatitis C
- +2 more
- Sofosbuvir/velpatasvir (Epclusa®)
-
Hazard, KentuckyARH Medical Mall
Sep 25, 2022
SARS-CoV-2 Infection, Influenza Viral Infections Trial in Brussels (blood samples, urine samples and nasopharyngeal swabs)
Recruiting
- SARS-CoV-2 Infection
- Influenza Viral Infections
- blood samples, urine samples and nasopharyngeal swabs
-
Brussels, BelgiumCliniques Universitaires Saint-Luc
Nov 2, 2022
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
Nasopharyngeal Carriage of Children and Adolescents Based on
Recruiting
- Pneumonia
- NP/OP swab
-
Baisha, Hainan, China
- +4 more
Jun 24, 2023
HIV Trial in France (Analytical Treatment Interruption (ATI))
Not yet recruiting
- HIV Infections
- Analytical Treatment Interruption (ATI)
-
Aix-en-Provence, France
- +29 more
Jul 28, 2022
Ataxia GAA-FGF14 - Descriptive Genetic and Clinical Study
Active, not recruiting
- Ataxia, Gait
-
Nancy, FranceCentre hospitalier régional universitaire
May 30, 2023
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Not yet recruiting
- Delirium, Postoperative
- +2 more
- (no location specified)
Sep 18, 2023
Drug Exposure and Minimum Inhibitory Concentration in Treatment
Not yet recruiting
- Mycobacterium Avium Complex
- +3 more
- Drug exposure
-
Shanghai, ChinaShanghai Pulmonary Hospital
Apr 10, 2023
Evaluating UTI Outcomes in at Risk Populations
Not yet recruiting
- Urinary Tract Infections
- Complicated Urinary Tract Infection
- Guidance UTI Test
- (no location specified)
Jun 6, 2022
Acute Coronary Syndrome With or Without ST Elevation 2010
Active, not recruiting
- Myocardial Infarction
- Acute Coronary Syndrome
-
Paris, FranceEuropean Hospital Georges Pompidou
Sep 20, 2022
End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])
Withdrawn
- End Stage Renal Disease
- Chronic Hepatitis c
- Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
-
Boston, MassachusettsMassachusetts General Hospital
Mar 4, 2022
HIV-positive People, Treated With Long Acting Antiretroviral
Active, not recruiting
- HIV Infections
- Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
-
Milan, ItalyOspedale San Raffaele Scientific Institute
Dec 15, 2022
NAFLD, Obesity, Morbid, Comorbidities and Coexisting Conditions Trial in Reus (To propose diagnostic tests for liver diseases
Recruiting
- NAFLD
- +2 more
- To propose diagnostic tests for liver diseases before surgical decisions.
-
Reus, Tarragona, SpainHospital Universitari Sant Joan
Sep 23, 2022
HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)
Active, not recruiting
- HIV-1-infection
- Switch to B/F/TAF
- Continue current regimen
-
Kisumu, Kenya
- +1 more
May 24, 2022
Platform for Clinical Trials in Nutrition and Health
Recruiting
- Healthy Volunteers
-
Madrid, SpainIMDEA Food
Mar 28, 2022